[Diagnosis and treatment of mastodynia]

Revue medicale de la Suisse romande · 1995 · vol. 115(5) , pp. 385–90 · PMID:7770685 · W71136017
Review OA: closed CC0
View on OpenAlex View on PubMed
⚙ AI-generated summary by qwen3.7-flash, 2026-09-27 ⓘ

This article reviews the diagnosis and treatment of mastodynia, noting that severe symptoms may be managed by modifying hormone therapies or using supplements and medications like danazol and tamoxifen.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Breast pain or mastalgia is a frequent complaint and it may represent various pathological conditions. After a thorough evaluation and reassurance of the patients, only those whose symptoms are severe enough to alter their life-style still require therapy. In some cases it will be indicated to modify or to stop an oral contraception or to adapt a hormone replacement therapy. Those women still resistant to treatment may experience relief from evening primrose oil supplements, bromocriptine, danazol, some progestins, tamoxifen or GnRH analogues. Therapy of non cyclic breast pain is made according to the underlying pathology. If no substrate is present, treatment is the same as for cyclical mastalgia but the response is diminished.

My notes (saved in your browser only)

MeSH descriptors

Breast Diseases Pain Adult Algorithms Breast Diseases Breast Diseases Breast Diseases Combined Modality Therapy Female Gonadotropin-Releasing Hormone Gonadotropin-Releasing Hormone Gonadotropin-Releasing Hormone Humans Menstruation Pain Pain Psychophysiologic Disorders Psychophysiologic Disorders Quality of Life

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-05-10T11:17:36.253347+00:00
pubmed
last seen: 2026-10-08T21:59:01.426159+00:00
License: CC0 · commercial use OK